Compare RWT & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RWT | EMBC |
|---|---|---|
| Founded | 1994 | 1924 |
| Country | United States | United States |
| Employees | 351 | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 707.5M | 524.1M |
| IPO Year | N/A | 2021 |
| Metric | RWT | EMBC |
|---|---|---|
| Price | $6.07 | $9.62 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | $6.91 | ★ $18.50 |
| AVG Volume (30 Days) | ★ 1.4M | 776.9K |
| Earning Date | 04-27-2026 | 05-08-2026 |
| Dividend Yield | ★ 11.90% | 6.34% |
| EPS Growth | N/A | ★ 20.90 |
| EPS | N/A | ★ 0.74 |
| Revenue | N/A | N/A |
| Revenue This Year | $26.59 | $1.17 |
| Revenue Next Year | $22.21 | N/A |
| P/E Ratio | ★ N/A | $12.78 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.00 | $8.47 |
| 52 Week High | $6.97 | $15.55 |
| Indicator | RWT | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 62.09 | 60.50 |
| Support Level | $5.91 | $8.60 |
| Resistance Level | $6.20 | $10.88 |
| Average True Range (ATR) | 0.14 | 0.37 |
| MACD | 0.07 | 0.14 |
| Stochastic Oscillator | 95.38 | 90.84 |
Redwood Trust Inc is a specialty finance company focused on several distinct areas of housing credit. The company delivers customized housing credit investments to a diverse mix of investors through securitization platforms, whole-loan distribution activities, and its publicly traded securities. The company has four reportable segments: Sequoia Mortgage Banking, CoreVest Mortgage Banking, Redwood Investments, and Legacy Investments. Maximum revenue is generated from the Sequoia Mortgage Banking segment, comprising a mortgage loan conduit that acquires residential consumer loans from third-party originators for subsequent sale to whole loan buyers, securitization through its SEMT private-label securitization program, or transfer into its Redwood Investments portfolio.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.